| Literature DB >> 35739823 |
Aliai Lanci1, Francesca Perina2, André Donadoni3, Carolina Castagnetti1,4, Jole Mariella1.
Abstract
Dystocia as a prolonged stage II parturition (>30 min) was associated with a higher risk of complications. The hypothesis of the study was that any type of dystocia could affect the foal's health, even when the stage II was <30 min. Clinical reports on 222 Standardbred mares and their foals hospitalized at the Veterinary Teaching Hospital of the University of Bologna from 2004 to 2020 were reviewed. Mares were divided into the Eutocia Group (165, eutocic delivery) and the Dystocia Group (57, dystocic delivery). The incidence of dystocia was 4.9%. Stage II was longer in the Dystocia Group (median 20 min) than in the Eutocia Group (median 12 min). All occurrences of dystocia were retrospectively classified into three categories of severity: mild, moderate and severe dystocia. The occurrence of postpartum complications in mares and neonatal diseases and failure of passive transfer of immunity in foals was higher in the Dystocia Group. Foal venous lactatemia and serum creatine kinase were significantly higher in the Dystocia Group (median 3.9 mmol/L; 262 UI/L respectively) than in the Eutocia Group (median 3.1 mmol/L; 187 UI/L respectively). The APGAR score was lower in the Dystocia Group (median 8) than in the Eutocia Group (median 10) and significantly lower in severe dystocia (median 3). The duration of stage II should not be considered the only parameter of dystocia in mares: even a rapid resolution of dystocia could pose health risks to the foal and the mare.Entities:
Keywords: Standardbred mare; categories of dystocia severity; causes of dystocia; dystocia; equine; foal blood parameters; foal health; foaling difficulty
Year: 2022 PMID: 35739823 PMCID: PMC9219446 DOI: 10.3390/ani12121486
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 3.231
Mare, fetal membrane and foal information in the Eutocia and Dystocia Groups. For quantitative variables (mare age, parity, gestation length, duration of stages II and III, umbilical cord length, total umbilical coils, umbilical coiling index, and foal weight), data are expressed as median (IQR). For categorical variables (high-risk pregnancy, fetal membrane and umbilical cord alterations, postpartum complications, failure of passive transfer of immunity (FPT), stillbirth, and sick foal), data are expressed as N (%). The different numbers of included animals for each parameter are due to missing data in the clinical reports.
| Eutocia Group | N | Dystocia Group (N = 57) | N |
| |
|---|---|---|---|---|---|
| Mare age (y) | 9 (7–12) | 165 | 9 (7–12) | 57 | |
| Mare parity (n) | 3 (1–5) | 165 | 3 (1–5) | 57 | |
| High-risk pregnancy (n) | 17 (10%) | 165 | 15 (26% ) # | 57 | 0.002 |
| Gestation length (days) | 340 (335–345) | 158 | 340 (334–348) | 54 | |
| Duration, stage II (min) | 12 (9–15) | 155 | 20 (13–27) * | 50 | <0.0001 |
| Duration, stage III (min) | 45 (30–90) | 150 | 60 (30–120) | 42 | |
| Fetal membrane alterations (n) | 28 (18%) | 155 | 21 (44%) # | 48 | 0.0003 |
| Umbilical cord alterations (n) | 12 (9%) | 139 | 10 (23%) | 44 | |
| Umbilical cord length (cm) | 54 (47–60) | 115 | 57 (48–69) | 36 | |
| Total umbilical coils (n) | 5 (4–6) | 102 | 5 (4–6) | 33 | |
| Umbilical coiling index | 0.09 (0.08–0.11) | 102 | 0.09 (0.08–0.10) | 33 | |
| Postpartum complications (n) | 30 (18%) | 165 | 25 (44%) # | 57 | 0.002 |
| Foal sex | 74 M; 91 F | 165 | 29 M; 20 F | 49 | |
| Foal weight (Kg) | 47 (43–51) | 165 | 48 (42–54) | 57 | |
| Stillborn foals (n) | 0 | 165 | 8 (14%) | 57 | |
| Sick foals (n) | 20 (12%) | 165 | 25 (51%) # | 49 | <0.00001 |
| Level 1 of care | 4/20 (20%) | 3/25 (12%) | |||
| Level 2 of care | 11/20 (55%) | 15/25 (60%) | |||
| Level 3 of care | 5/20 (25%) | 7/25 (28%) | |||
| FPT (n) | 7 (5%) | 145 | 8 (23%) # | 35 | 0.0023 |
* indicates a significant difference between the two groups in the row (quantitative variables). # indicates a significant difference between the two groups in the row (categorical variables).
Foal clinical parameters and rapid determination performed at foaling in the Control Group (healthy foals) and the Dystocia Group (healthy and sick foals born alive). For quantitative variables (APGAR score, body temperature, time to acquire sternal recumbency, sucking reflex, standing position, first intake of colostrum and rapid determination performed at foaling), data are expressed as medians (IQR). For categorical variables (Failure of passive transfer of immunity (FPT), stillbirths, sick foals), data are expressed as number of subjects (%). Different numbers of included animals for each parameter are due to missing data in the clinical reports.
| Control Group (N = 134) | Dystocia Group (N = 49) | ||||
|---|---|---|---|---|---|
| APGAR score | 10 (9–10) | 134 | 8 (6–9) * | 49 | <0.0001 |
| Body temperature (°C) | 37.7 (37.5–37.9) | 134 | 37.6 (37.3–37.9) | 46 | |
| Time to sternal recumbency (min) | 2 (1–5) | 134 | 4 (1–8) | 39 | |
| Time to suckling reflex (min) | 20 (12–31) | 134 | 33 (15–56) * | 38 | 0.0044 |
| Time to standing position (min) | 68 (57–90) | 129 | 70 (60–92) | 36 | |
| Time to first intake of colostrum (min) | 116 (95–136) | 134 | 95 (64–130) *,a | 42 | 0.0087 |
| Amniotic fluid lactate (mmol/L) | 16.3 (14.2–18.4) | 102 | 14.9 (12.8–17.3) * | 40 | 0.0357 |
| Mare jugular lactate (mmol/L) | 1.9 (1.3–2.5) | 64 | 2.1 (1.6–2.9) | 21 | |
| Foal jugular lactate (mmol/L) | 3.1 (2.6–4.2) | 128 | 3.9 (2.8–6.5) * | 41 | 0.0037 |
| Foal jugular glucose (mmol/L) | 4.61 (3.77–5.66) | 130 | 4.83 (3.27–5.88) | 46 |
* indicates a significant difference between the two groups in the row (quantitative variables). a Foals in the Dystocia Group received colostrum by independent suckling or assisted feeding through a nasogastric tube.
Foal venous blood gas analysis at birth in the Control Group and the Dystocia Group. Data are expressed as medians (IQR). No significant differences were found. In the Dystocia Group, foals for which venous blood gas analysis was available at birth were born after mild (5/9), moderate (2/9) and severe dystocia (2/9); 3/9 foals (33%) in the Dystocia Group were healthy and 6/9 foals (67%) were sick.
| Control Group | Dystocia Group | |
|---|---|---|
| pH | 7.33 (7.30–7.37) | 7.31 (7.26–7.37) |
| pO2 (mmHg) | 39 (33–42) | 35 (32–40) |
| SO2 (%) | 72 (63–75) | 65 (60–78) |
| pCO2 (mmHg) | 58 (56–60) | 59 (53–61) |
| HCO3 (mmol/L) | 28.8 (28.3–30.2) | 27.2 (25.5–28.1) |
| Anion gap (mmol/L) | 18.4 (17.5–19.5) | 17.8 (16.3–19.3) |
| tCO2 (mmol/L) | 30.5 (30.2–32.1) | 29.3 (27.4–31.3) |
| Base excess (mmol/L) | 2.0 (0.86–3.0) | −0.70 (−2.77–1.77) |
| Na+ (mmol/L) | 151 (146–152) | 150 (146–152) |
| K+ (mmol/L) | 3.7 (3.4–4.2) | 4.1 (3.6–4.4) |
| Cl− (mmol/L) | 107 (105–107) | 106 (106–109) |
Foal CBC and blood chemistry at birth in the Control Group and the Dystocia Group. Data are expressed as medians (IQR) and min–max values. Different numbers of included animals for each parameter are due to missing data in the clinical reports.
| Control Group | N | Dystocia Group | N |
| |
|---|---|---|---|---|---|
| Hb (g/dL) | 15.5 (14.8–16.1) | 134 | 14.6 (13.7–15.8) * | 47 | 0.005 |
| Hct (%) | 46.2 (44–49) | 134 | 44.8 (41.2–47.9) * | 47 | 0.0247 |
| RBCs × 103/mm3 | 10,920 (10,423–11,500) | 134 | 10,370 (9790–10,868) * | 47 | 0.0002 |
| Platelets × 103/mm3 | 207 (174–241) | 134 | 194 (163–232) | 47 | |
| WBCs/mm3 | 7910 (6972–9032) | 134 | 7290 (6175–8167) * | 47 | 0.0050 |
| Neutrophils/mm3 | 6205 (5135–7013) | 126 | 5430 (4622–6291) * | 47 | 0.0029 |
| Lymphocytes/mm3 | 1350 (1150–1601) | 126 | 1390 (1098–1915) | 47 | |
| CK (U/L) | 187 (142–243) | 114 | 262 (183–377) * | 40 | 0.0007 |
| Total Bilirubin (µmol/L) | 35.91 (29.07–44.46) | 114 | 35.91 (29.07–41.04) | 40 | |
| Triglycerides (mmol/L) | 0.11 (0.08–0.12) | 26 | 0.1 (0.09–0.15) | 46 | |
| Total Protein (g/L) | 42 (40–44) | 116 | 40 (38–43) | 18 | |
| Albumin (g/L) | 33 (32–35) | 116 | 32 (29–34) * | 46 | 0.0126 |
| Albumin/Globulin | 4.1 (3.6–4.7) | 116 | 3.7 (3.3–4.3) | 46 | |
| Urea (mmol/L) | 13 (11.39–14.64) | 118 | 12.78 (10.78–14.21) | 46 | |
| Creatinine (µmol/L) | 221.05 (194.52–256.42) | 118 | 238.73 (194.52–318.31) | 46 | |
| Phosphorus (mmol/L) | 1.74 (1.58–1.87) | 27 | 1.8 (1.55–1.93) | 18 | |
| Calcium (mmol/L) | 3.22 (3.15–3.32) | 114 | 3.35 (3.2–3.57) * | 40 | 0.0032 |
| Magnesium (mmol/L) | 0.73 (0.69–0.78) | 114 | 0.73 (0.69–0.82) | 45 | |
| Fibrinogen (g/L) | 3.2 (1.7–4.1) | 108 | 2.0 (1.7–3.2) | 43 | |
| IgG within 24 h (mg/dL) | 1659 (1144–2315) | 116 | 900 (827–1440) * | 38 | 0.0001 |
* Indicates a significant difference between the two groups in the row.
The three categories of dystocia severity in relation to cause of dystocia, condition of the foal and mare, and mortality rate.
| Category of Dystocia Severity | Cause of Dystocia | Foal Condition | Postpartum | Mortality Rate |
|---|---|---|---|---|
| Mild | Maternal (9/35) | Healthy 20/35 | 15/35 | Mares 6% (2/35) |
| Fetal (17/35) | ||||
| Fetal membranes (6/35) | ||||
| More than one (3/35) | ||||
| Moderate | Maternal (1/10) | Healthy 3/10 | 3/10 | Mares 0% |
| Fetal (3/10) | ||||
| Fetal membranes (1/10) | ||||
| More than one (5/10) | ||||
| Severe | Maternal (1/12) | Healthy 1/12 | 3/12 | Mares 25% (3/12) |
| Fetal (9/12) | ||||
| Fetal membranes (0/12) | ||||
| More than one (2/12) |
Causes of dystocia and information regarding stillbirth and foal and mare mortality. Data are expressed as % (n).
| Causes of Dystocia | Specific Causes % (n) | Stillbirth | Foal | Mare |
|---|---|---|---|---|
| Maternal causes | Primary uterine inertia 45.5% (5/11) [ | 0% | 0% | 0% |
| Weak abdominal straining 36.4% (4/11) [ | ||||
| Incomplete cervical dilation 18.2% (2/11) [ | ||||
| Fetal causes | Abnormal fetal posture 72.4% (21/29) | 21% | 6.9% | 6.9% |
| Abnormal fetal position 17.2% (5/29) | ||||
| Abnormal fetal presentation 7% (2/29) | ||||
| Congenital deformities 3.4% (1/29) | ||||
| Fetal membrane causes | Premature placental separation 86% (6/7) | 0% | 14.3% | 14.3% |
| Umbilical cord twisting 14% (1/7) | ||||
| More than one cause | Abnormal fetal position and secondary uterine inertia 30% (3/10) | 20% | 10% | 20% |
| Premature placental separation and abnormal fetal presentation 20% (2/10) | ||||
| Incomplete cervical dilation and abnormal fetal position 10% (1/10) | ||||
| Weak abdominal straining and abnormal fetal posture 10% (1/10) | ||||
| Premature placental separation, secondary uterine inertia, and abnormal fetal position 10% (1/10) | ||||
| Abnormal fetal posture and secondary uterine inertia 10% (1/10) | ||||
| Premature placental separation and secondary uterine inertia 10% (1/10) |
Significantly different parameters among the different causes of dystocia reported. Data are expressed as medians (IQR) and min–max values.
| Maternal Causes (n = 11) | Fetal Causes (n = 29) | Fetal Membrane Causes (n = 7) | More Than One Cause (n = 10) |
| |
|---|---|---|---|---|---|
| Duration of stage II (min) | 21 (18–25) a | 22 (14–34) a | 7 (4–11) b | 26 (14–50) a | 0.0386 |
| APGAR score | 9 (8–10) a | 8 (7–9) b | 8 (5–9) bc | 6 (2–7) c | 0.0011 |
| Foal CK (U/L) | 339 (223–449) a | 207 (144–271) b | 397 (320–447) a | 323 (237–454) a | 0.0185 |
| Foal urea (mg/dL) | 40 (36–48) a | 34 (29–38) b | 34 (30–39) b | 31 (29–37) b | 0.0193 |
a, b, c Different superscript letters indicate a significant difference among the four groups in the row.
Significantly different parameters among the different categories of dystocia severity reported. Data are expressed as medians (IQR) and min–max values. A total of 35/57 foals were born from Mild dystocia (20/35 foals were healthy; 15/35 foals were sick); 10/57 foals were born from Moderate dystocia (2/10 foals were stillborn, 3/10 foals were healthy and 5/10 foals were sick); 12/57 foals were born from Severe dystocia (6/12 foals were stillborn, 1/12 foals were healthy and 5/12 foals were sick).
| Mild Dystocia | Moderate Dystocia (n = 10) | Severe Dystocia (n = 12) |
| |
|---|---|---|---|---|
| Duration of stage II (min) | 16 (11–24) a | 25 (22–30) b | 75 (62–112) c | 0.0001 |
| APGAR score | 9 (8–9) a | 5 (3–8) b | 3 (0–5) b | <0.0001 |
| Foal Hb (g/dL) | 14.5 (13.7–15.4) a | 16 (14.9–16.2) a | 13.4 (11.3–14.2) b | 0.0033 |
| Foal Hct (%) | 44.9 (41.3–47.4) a | 44.8 (43.4–51.1) a | 39.9 (36.3–41.5) b | 0.0048 |
| Foal RBCs × 103/mm3 | 10375 (9898–10861) a | 11095 (10286–11807) a | 8700 (8283–9390) b | 0.0044 |
| Foal total proteins (g/dL) | 4.1 (3.9–4.3) a | 4.2 (3.7–4.3) ab | 3.5 (3.2–3.9) b | 0.0417 |
| Foal calcium (mg/dL) | 13.1 (12.6–13.6) a | 13.8 (13.3–14.3) ab | 14.7 (14.4–15.1) b | 0.0141 |
a, b, c Different superscript letters indicate a significant difference among the three groups in the row.